|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 309.66 USD | -1.20% |
|
-0.36% | +1.93% |
| 11/04 | BeOne Medicines Says Tarlatamab Received Marketing Authorization in China for Small Cell Lung Cancer Treatment | MT |
| 10/04 | Wall Street Gets a CPI Lifeline |  |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Neutral |
| Resistance | 313.42 | 320.37 | 365.82 |
| Spread/Res. | -1.20% | -3.34% | -15.35% |
| Spread/Supp. | +5.71% | +12.71% | +35.59% |
| Support | 292.94 | 274.73 | 228.38 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- ONC Stock
- Charts BeOne Medicines AG
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition